Morris Matthew Shawn sold $3.6M of PRVA
Morris Matthew Shawn sold 135,498 shares of Privia Health Group, Inc. (PRVA) at an average of $26.32 ($25.72–$26.93, $3.57M total) across 3 trades over 2026-06-30 to 2026-07-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the record of insider activity and may influence short-term sentiment, but it does not introduce new company-specific operating or financial information.
Market read
Traders may note the insider sale size ($3.57M) and 10b5-1 context, but there is no fundamental catalyst in the text.
What to watch
The filing does not state motivations, and the sales were spread across three trades with a stated weighted average price, limiting inference about timing or new information.
Background
This is an SEC Form 4 insider transaction for Privia Health Group, Inc. (PRVA), reported by a director.
Ticker impact
Privia Health Group director Morris Matthew Shawn sold $3.57M of PRVA shares via an open-market sale under a pre-arranged 10b5-1 plan.
Likely limited immediate price impact; any effect is more sentiment/flow-related than fundamental.
Form 4 shows a director’s planned open-market sale with a 10b5-1 plan, which typically reduces signaling value versus discretionary selling. The article provides no accompanying company news (earnings, guidance, deals, or regulatory actions).
Market effects
Minimal; insider sale in a single healthcare services name does not materially change sector fundamentals.
None indicated.
None indicated.
Counterpoint
A large director sale can still be interpreted as risk management or diversification, but it is often not bearish when executed under a 10b5-1 plan.
Key entities
- issuerPrivia Health Group, Inc.
Subject of the Form 4 insider sale disclosure.
- insiderMorris Matthew Shawn
Director who sold 135,498 PRVA shares under a pre-arranged 10b5-1 plan.
